Minimally invasive surgery and chemotherapy for colorectal cancer have seen significant advancements, particularly with the rise of robotic-assisted procedures. The number of robotic-assisted colorectal surgeries has surged, and the scope of these procedures, including lateral lymph node dissection and combined organ resection, is broadening. Despite these advancements, the comparative effectiveness of robotic-assisted surgery versus traditional laparoscopic or open surgery remains unclear. Additionally, the treatment of locally advanced rectal cancer is evolving, with a focus on total neoadjuvant therapy (TNT) strategies that incorporate preoperative radiotherapy and chemotherapy. Immunotherapy has also emerged as a promising option for select patients, necessitating personalized treatment plans to optimize the safety and efficacy of multimodal approaches. While current studies have provided insights into preoperative treatments and surgical techniques, there remains a need for further exploration of innovative strategies to address existing challenges and enhance treatment outcomes.
This research topic aims to explore the recent advances and challenges in robotic-assisted colorectal surgery and chemotherapy for colorectal cancer. The primary objectives include evaluating the effectiveness of robotic-assisted surgery compared to conventional methods, understanding the role of multidisciplinary approaches in treating locally advanced rectal cancer, and identifying innovative strategies to standardize and improve minimally invasive surgical techniques. Key questions include the comparative benefits of robotic surgery, the integration of immunotherapy in treatment plans, and the development of individualized strategies to enhance patient outcomes.
To gather further insights in the field of minimally invasive surgery and chemotherapy for colorectal cancer, we welcome articles addressing, but not limited to, the following themes:
- Comparative studies on robotic-assisted versus traditional surgical methods
- Innovations in lateral lymph node dissection and combined organ resection
- Total neoadjuvant therapy (TNT) strategies and their impact on treatment outcomes
- The role of immunotherapy in multimodal treatment plans
- Standardization and optimization of robotic-assisted surgical techniques
- Patient-specific strategies for maximizing curative and function-preserving outcomes
- Current complications in minimally invasive surgery and strategies to overcome them
Minimally invasive surgery and chemotherapy for colorectal cancer have seen significant advancements, particularly with the rise of robotic-assisted procedures. The number of robotic-assisted colorectal surgeries has surged, and the scope of these procedures, including lateral lymph node dissection and combined organ resection, is broadening. Despite these advancements, the comparative effectiveness of robotic-assisted surgery versus traditional laparoscopic or open surgery remains unclear. Additionally, the treatment of locally advanced rectal cancer is evolving, with a focus on total neoadjuvant therapy (TNT) strategies that incorporate preoperative radiotherapy and chemotherapy. Immunotherapy has also emerged as a promising option for select patients, necessitating personalized treatment plans to optimize the safety and efficacy of multimodal approaches. While current studies have provided insights into preoperative treatments and surgical techniques, there remains a need for further exploration of innovative strategies to address existing challenges and enhance treatment outcomes.
This research topic aims to explore the recent advances and challenges in robotic-assisted colorectal surgery and chemotherapy for colorectal cancer. The primary objectives include evaluating the effectiveness of robotic-assisted surgery compared to conventional methods, understanding the role of multidisciplinary approaches in treating locally advanced rectal cancer, and identifying innovative strategies to standardize and improve minimally invasive surgical techniques. Key questions include the comparative benefits of robotic surgery, the integration of immunotherapy in treatment plans, and the development of individualized strategies to enhance patient outcomes.
To gather further insights in the field of minimally invasive surgery and chemotherapy for colorectal cancer, we welcome articles addressing, but not limited to, the following themes:
- Comparative studies on robotic-assisted versus traditional surgical methods
- Innovations in lateral lymph node dissection and combined organ resection
- Total neoadjuvant therapy (TNT) strategies and their impact on treatment outcomes
- The role of immunotherapy in multimodal treatment plans
- Standardization and optimization of robotic-assisted surgical techniques
- Patient-specific strategies for maximizing curative and function-preserving outcomes
- Current complications in minimally invasive surgery and strategies to overcome them